NFKB1 and glioblastoma: Many other preclinical studies have demonstrated the ability of antidepressants to affect glioblastoma growth.[34, 41–43] For example, studies have demonstrated the ability of fluoxetine to inhibit NF-κB signaling, inducing apoptosis in glioblastoma cells [10].